PE01.01 Screening for common mental disorders among anti-retroviral therapy (ART) users: Implications of case-finding for treatment of mental disorders, ART adherence and viral suppressionE-posterBehavioural and social science research
OA03.01 Safety and single-dose pharmacokinetics of VRC07-523LS administered via different routes and dosesOral Abstract SessionClinical trial results
OA03.02 Safety and PK of Potent Anti-HIV Monoclonal AB VRC07-523LS in HIV-exposed InfantsOral Abstract SessionBroadly neutralizing antibodies
OA05.01 Role of HLA-E antigen presentation on NK control of HIV infection Oral Abstract SessionInnate and trained immunity
OA02.05LB Risk factors for HIV transmission in heterosexual men, men who have sex with men, and transgender women participating in the HVTN 702 'Uhambo' and HVTN 503/503-S 'Phambili' HIV vaccine trialsOral Abstract SessionTransmission of HIV
PE01.18 Response to a novel technology-assisted HIV self-testing intervention in Kampala, Uganda by age and gender.E-posterBehavioural and social science research
PE11.14 Relationship between lifetime and recent experiences of violence on HIV-related health-seeking behavior among women in Malawi and Zambia as captured in the Population-based HIV Impact Assessment (PHIA) SurveysE-posterEpidemiology of HIV
OA17.05 Redefining ownership: the mismatch between female sex workers' research priorities and the field in KenyaOral Abstract SessionCommunity engagement in prevention research
PE05.09 Recruitment of participants into an HIV vaccine preparedness study: experiences from Masaka, UgandaE-posterCommunity engagement in prevention research
PE05.01 Recruiting adolescent girls and young women into the MTN-034 Study: lessons learnt from the Kampala and Johannesburg sitesE-posterCommunity engagement in prevention research
seek-warrow-warrow-eseek-e101 - 110 of 444 items